PDF
ePub
Citation
Print
Abstract
Anemia is one of the important causes compromising normal growth, development, and immune function in children. In outpatient clinics, we can see patients with anemia caused by various etiologies, whether congenital or acquired. Most cases of childhood anemia are caused by incomplete supplements of nutrients for erythropoiesis, despite the improved socioeconomic situation. Sometimes we need to treat the underlying diseases to correct the anemia. Also, we have to evaluate the etiology of anemia according to age, and consider medical treatments on the basis of the underlying causes. In this article, the author reviews pharmacotherapy in childhood anemia.
References
1. Moy RJD. Prevalence, consequences and prevention of childhood nutritional iron deficiency: a child public health perspective. Clin Lab Haem. 2006. 28:291–298.
2. The Korean Society of Hematology. Cha YJ, editor. Classification of anemia. Hematology. 2006. 1st ed. Seoul: E-public;44–46.
3. Bourke B, Ceponis P, Chiba N, Czinn S, Ferraro R, Woodland R, et al. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents-an evidence-based evaluation. Can J Gastroenterol. 2005. 19:399–408.
4. The Korean Society of Pediatrics. Ahn HS, editor. Blood disorders. Pediatrics. 2004. 8th ed. Seoul: Daehan Printing & Pubishing Co., Ltd;813–817.
5. The Korean Society of Hematology. Cha YJ, editor. Disorder of iron metabolism. Hematology. 2006. 1st ed. Seoul: E-public;75–81.
6. Yun DJ, Lee H, Chun GP, Lee KY. Juvenile pernicious anemia in sisters. Yonsei Med J. 1967. 8:71–76.
7. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006. 4:236–241.
8. The Korean Society of Hematology. Cha YJ, editor. Megaloblastic anemia. Hematology. 2006. 1st ed. Seoul: E-public;90–100.
9. Sackey K. Hemolytic anemia. Pediatr Rev. 1999. 20:152–158.
10. Kellermayer R, Faden H, Grossi M. Clinical presentation of parvovirus B19 infection in children with aplastic crisis. Pediatr Infect Dis J. 2003. 22:1100–1101.
11. Park SJ, Yang WS, Hwang HS, Jang PS, Kim HH, Kim JH, Koh DK, Lee KY, Cho B, Jeong DC, Kim HK. Clinical Manifestations and Factors Associated with Complications and Splenectomy in Hereditary Spherocytosis. Clin Pediatr Hematol-Oncol. 2006. 13:158–166.
12. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Alberti D, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with-thalassmia. Blood. 2006. 107:3455–3462.
13. The korean Society of Hematology. Cha YJ, editor. Autoimmune hemolytic anemia. Hematology. 2006. 1st ed. Seoul: E-public;125–130.
14. Gottardo NG, Baker DL, Willis FR. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab. Pediatr Hematol Oncol. 2003. 20:557–561.
15. Di Raimondo F, Giustolisi R, Cacciola E, O'Brien S, Kantarjian H, Robertson LB, Keating MJ. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma. 1993. 11:63–68.
16. Jeong DC, Kang IJ, Koo HH, Kook H, Kim SY, Hwang TJ, et al. Epidemiology and Clinical Outcomes in Children with Aplastic Anemia in Korea: Retrospective Study. Korean J Pediatr Hematol-Oncol. 2004. 11:137–152.
17. Young NS. Immunosuppressive treatment of acquired aplastic anemia and immne-mediated bone marrow failure syndrome. Int J Hematol. 2002. 75:129–140.
18. Young NS, Calado RT, Scheinberg P. Current concepts in pathophysiology and treatment of aplastic anemia. Blood. 2006. 108:2509–2519.
19. Marwaha RK, Bansal D, Trehan A, Marwaha N, Varma N. Clinico-haematological profile of pure red cell aplasia in children. J Trop Pediatr. 2002. 48:113–116.
XML Download